We are heading up a newborn sequencing consortium that will revolutionize and shorten the diagnostic journey.
We are transforming pediatric healthcare through the power of Rapid Precision Medicine™
We’re setting a new standard of care for newborns and children with rare undiagnosed diseases.
Join our dynamic team of professionals from around the world
GTRx, a clinical decision support tool, can provide front-line clinicians with the information they need to initiate precision treatments for critically ill infants and …
PHARMAVOICE: Newborn screening is gaining prominence across the biopharma and healthcare industries amid efforts to detect and treat disease as early as possible.
SD UNION-TRIBUNE: A new initiative from the Rady Children’s Institute for Genomic Medicine hopes to screen newborns for nearly 400 genetic conditions.
Tuesday September 20, 2022 | 11:15am ET
Saturday September 10, 2022 | 11am PT
*Free Registration is required
Rapid Precision Medicine™ is here now. We are setting the standard for pediatric critical care by breaking barriers to expand access to genomically-informed, personalized care nationwide. We offer many opportunities to collaborate with as we work to save and improve lives.
© 2022 Rady Children's Institute for Genomic Medicine.
